Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir

Authored by: van Vonderen M. G. A., Gras L., Wit F., Brinkman K., van der Ende M. E., Hoepelman A. I. M., de Wolf F., Reiss P.
In: HIV CLINICAL TRIALS 10(3), 2009, p.168-180